Referencias

Referencias
1. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995; 36 Supp2: 46-65.
2. Sommerfeld-Zisking E, Zinkind E. Effect of phenobarbital on the mentality of epileptic patients. Arch Neurol Psychiatry 1940; 43:70-79.
3. Lennox WG. Brain injury, drugs and environment as causes of mental decay in epilepsy. Am J Psychiatry 1942; 99:174-180.
4. Meldrum BS. Update on the mechanisms of action of antiepileptic drugs. Epilepsia 1996; 37 (6): 4-11.
5. Engel J, Bandler R, Griffith NC, et al. Neurobiological evidence for epilepsy-induced interictal disturbances. En. Smith DB, Treiman DM, Trimble MR, editores. Neurobehavioral Problems in Epilepsy. New York: Raven Press; 1991. p. 97-111.
6. Nichols ME, Meador KJ, Loring DW. Neuropsychological effects of antiepileptic drugs: a current perspective. Clin Neuropharmacol 1993; 16: 471-84.
7. Meador KJ. Cognitive effects of antiepileptic drugs. Canadian Journal of Neurological Sciences 1994; 21(3): 12-16.
8. Vermeulen J, Aldenkamp AP. Cognitive side effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Research 1995; 22: 65-95.
9. Kälviäinen R, Äikiä M, Riekkinen PJ. Cognitive adverse effects of antiepileptic drugs. incidence mechanisms and therapeutic implications. CNS Drugs 1996; 5: 358-68.
10. Drane DL, Meador KJ. Epilepsy, anticonvulsant drugs and cognition. Baillière’s Clinical Neurology 1996; 34: 877-85.
11. Milano Collaborative Group of Studies on Epilepsy. Long-term intensive monitoring in the difficult patient: preliminary results of 16 months of observation-usefulness and limitations. En: Gardner-Thorpe, editores. Antiepileptic drug monitoring. Tunbridge Wells, England: Pitman, 1977; 197-213.
12. Schain RJ, Ward JW, Guthrie D. Carbamazepine as an anticonvulsant in children. Neurology 1977; 27:476-480.
13. Shorvon SD, Reynolds EH. Reduction of polipharmacy for epilepsy. BMJ 1979; 2: 1023-25.
14. Thompson P, Trimble MR. Anticonvulsant drugs and cognitive functions. Epilepsia 1982; 23: 531-44.
15. Ludgate J, KeatingJ, O’Dwyer R, Callaghan N. An improvement in cognitive function following polypharmacy reduction in a group of epileptic patients. Acta Neurol Scand 1985; 71:448-452.
16. Prevey ML, Mattson RH, Cramer JA. Improvement in cognitive functioning and mood state after conversion to valproate monotherapy. Neurology 1989; 39: 1640-1.
17. Tchicalof M, Gaillard F. Quelques effets indesirables des medicaments antiepileptiques, sur le rendements intellectuels. Rev Neuropsychol infant 1970; 18: 599-602..
18. Reynolds EH, Travers RD. Serum anticonvulsant concentration in epileptic patients with mental symtoms. Br J Psychiatry 1974; 124: 440-5.
19. Debakan AS, Lehman EJB. Effects of different dosages of anticonvulsant drugs on mental performances in patients with chronic epilepsy. Acta Neurol Scand 1975; 52: 19-30.
20. Thompson PJ, Trimble MR. Anticonvulsant serum levels: relationship to impairment of cognitive functioning. J Neurol Neurosurg Psychiatry 1983; 46: 227-3.
21. Aldenkamp AP, Alpherts WCJ, Blennow G. Et al. Withdrawal of antiepileptic medication in children - effects on cognitive function: the multicenter holmfrid study. Neurology. 1993; 43: 41-50.
22. Gaily EK, Granström ML, Hiilesmaa WK et al.. Head cicumference in children of epileptic mothers: contribution of drug exposure and genetic background. Epilepsy Research 1990; 5: 217-22.
23. Ramson BR, Elmore JG.. Effects of antiepileptic drugs on developing central nervous system. En: Smith DB, Treiman DM, Trimble MR editores. Neurobehavioral Problems in Epilepsy. Advances in Neurology Vol 55. New York: Raven Press; 1991. p. 225-37.
24. Morselli PL. Pharmacokinetics in infancy, childhood and adolescence. En: Willie E. Editor. The Treatment of Epilepsy. Philadelphia: Lea & Febiger; 1993. p. 752-68.
25. Fishman RAB, Yanai J. Long-Lasting effects of early barbiturates on central nervous system and behavior. Neuroscience and Biobehavioral Reviews 1983; 7: 19-28.
26. Dansky LV, Finnell RH. Parental epilepsy anticonvulsant drug and reproductive outcome: epidemiologic and experimental findings spanning three decades, 2: human studies. Reproductive Toxicology Reviews 1991; 5: 301-35.
27.
28. Craig Y, Tallis R... The impact of sodium valproate and phenitoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994; 35: 301-35.
29. Ounsted C. The hiperkinetic syndrome in epileptic children. Lancet 1955; 2: 303-11.
30. Camfield CS, Chaplin S, Doyle AB, Shaphiro SH, Cummings C, Campfield PR. Side effects of phenobarbital in toddlers, behavioral and cognitive aspects. J Pediatrics 1979; 95: 361-65.
31. Bourgeois BFD, Prensky AL, Palkes H.S, Talent BK, Busch SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983; 14: 438-44.
32. Corbert JA, Trimble MR, Nichol RC.. Behavioral and cognitive impairments in children with epilepsy: the long-term effects of anticonvulsant therapy. J Am Acad Child Psychiatry 1985; 24: 17-23.
33. Vining EPG, Mellits ED, Dorsen MM et al.. Psychological and behavioral effects of antiepileptic drugs in children: a double-blind comparision between phenobarbital and valproic acid. Pediatrics 1987; 80: 165-74.
34. Mitchell WG, Chavez JM. Carbamazpine versus phenobarbital for partial onset seizures in children. Epilepsia 1987; 28: 56-60.
35. Calandre EP, Dominguez-Granados, R, Gomez-Rubio M et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990; 81: 504-506.
36. Herranz JL, Armijo JA, Arteaga R. Clinical side effects of phenobarbital primidone, phenytoin, carbamazepine and valproate during monotherapy in children. Epilepsia 1988; 29: 794-804.
37. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures-effects on intelligence and seizure recurrence. New England Journal of Medicine 1990; 322: 364-69.
38. Macleod CM, Dekaban AS, Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 1978; 202: 1102-42.
39. Hutt SJ, Jackson PM, Belsham A, Higgins G. Perceptual-motor behaviour in realtion to blood phenobarbitone level: a prelimiary report. Dev Med Child Neurol 1968; 10: 626-32.
40. Stores G, Hart J. Reading skills of children with generalized or focal epilepsy attending ordinary school. Dev Med Child Neurol 1976; 18: 705-16.
41. Aman MG, Werry JS, Paxton W, Turbott SH. Effects of phenytoin on cognitive-motor performance in children as a function of drug concentration, seizure type and time of medication. Epilepsia 1994; 35: 172-80.
42. Tonnby B, Nilsson H. Aldenkamp AP et al. Withdrawal of antiepileptic medication in children – Correlation of cognitive function and plasma concentration – The multicentre "Holmfrid" study. Epilepsy Res 1994; 19: 141-152.
43. Andrewes DG, Bullen JG, Tomlinson L, Elwes RDC, Reynolds EH. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia 198;. 27: 128-34.
44. Gallassi R, Morreale A, Lorusso S et al. Cognitive effects of phenytoin during monotherapy and after withdrawal. Acta Neurol Scand 1987; 75: 258-261.
45. Duncan JS, Shorvon SD, Trimble MR. effects of removal of phenytoin carbamazepine and valproate on cognitive function. Epilepsia 1990; 31: 584-91.
46. Dodrill CB, Troupin AS. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparision with phenytoin. Neurology 1977; 27: 1023-28.
47. Dodrill CB, Troupin AS. Neuropsychological effects of carbamazepine and phenytoin: A reanalysis. Neurology 1991; 41: 141-143.
48. Ideström CM, Schalling D, Carlquist U et al. Behavioral and psychological studies: Acute effects of diphenyl-hydantoin in relation to plasma levels. Psychol Med 1972; 2: 111-120.
49. Stephens JH, Schaffer JW, Brown CC. A controlled comparison of the effect of diphenylhydantoin and placebo on mood and psychomotor functioning in normal volunteers. J Clin Pharmacol 1974; 14: 543-551.
50. Smith WL, Lowrery JB. Effects of diphenylhydantoin on mental habilities in elderly. J Am Geriatr Soc 1975; 23: 207-211.
51. Thompson PJ, Huppert F, Trimble MR. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand 1980; 23: 207-211.
52. Thompson PJ, Huppert FA., Trimble MR. Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy. Br J Clin Pharmacol 1981; 20: 155-62.
53. Trimble MR. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987; 28 (3): 37-45.
54. Dodrill CB.. Effects of antiepileptic drugs on behavior. En: Devinsky O. Theodore WH, editores. Epilepsy and behavior. New York: Wiley-Liss; 1991.p. 37-46..
55. Forsythe WI, Sills MA. One drug for chilhood grand mal: medical audit for three year remisions. Dev Med Child Neurol 1984; 26: 742-8.
56. O’Dougherty M, Wright FS, Cox S, Walson P. Carbamazepine plama concentration: relationship to cognitive impairment. Arch Neurol 1987; 44: 863-7.
57. Amman MG, Werry JS, Paxton JW et al. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type and time of medication. Epilepsia 1990; 31: 51-60.
58. Forsythe I, Butler R, Berg I et al. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991; 33: 524-534.
59. Dalby MA. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy. Epilepsia 1971; 12: 325-34.
60. Macfee GJA, McPhail EM, Butler E, Brodie MJ. Controlled evaluation of a supplementary dose of carbamazapine on psychomotor function in epileptic patients. Eur J Clin Pharmacol 1986b; 31: 195-99.
61. Meador KJM, Loring DW, Huh K et al. Comparative cognitive effects of anticonvulsants. Neurology 1990; 40: 391-394.
62. Ghillham RA, Williams N, Weidermann KD et al. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res 1990; 7: 219-225.
63. Rönnberg J, Samuelsson S, Söderfeldt K. Memory effects following carbamazepine monotherapy in patients with complex partial epilpsy. Seizure 1992; 1: 247-253.
64. Helmstaedter C, Wagner G, Elger CE. Differential effects of first antiepileptic drug application on cognition in lesional and non-lesional patients with epilepsy. Seizure 1993; 2: 125-30.
65. Mitchell WG, Chavez JM, Zhou Y, Guzman BL. Carbamazepine influences reaction time and impulsivity in children with epilepsy. Epilepsia 1988; 29: 681.
66. Okuma T, Inanaga K, Otsuki S et al. A preliminary double-blind study of the efficacy of carbamazepine in prophilaxis of manic-depressive illness. Psychopharmacology 1981; 73: 95-6.
67. Post RM, Uhde T.W, Ballenger JC, Squillance KM. Prophilactic effect of carbamazepine in manic-depressive illness. Am J Psychiatry 1983; 140: 1602-04.
68. Post RM, Altsthuleer LL, Ketter TA, Denikoff K, Weiss SB. Antiepileptic drugs in affective illness: clinical and theoretical implications. En Smith DB, Treiman DM, Trimble MR editores. Neurobehavioral Problems in Epilepsy. New York: Raven Press; 1991. p. 239-77.
69. Carpenter WT Jr, Kurtz R, Kirpatrick P, Et al.. Carbamazepine maintenance therapy with outpatients. Arch Gen Psychiatry 1991; 48: 69-72.
70. Aman MG, Werry JS, Paxton JW, Turbott SH. Effect of sodium valproate on psychomotor performance in children as a function of dose fluctuations in concentration and diagnosis. Epilepsia 1987; 28: 115-28.
71. Sommerbeck KW, Theilgaard A, Rasmussen KE. Valproate sodium: Evaluation of so-called psychotropic effect. A controlled Study. Epilepsia 1977; 18: 159-162.
72. Gallassi R, Morreale A, Lorusso S, Procaccianti G, Lugaresi E, Baruzzi A. Cognitive effects of valproate. Epilepsy Res 1990; 5: 160-4.
73. Thompson PJ, Trimble MR. Sodium Valproate and Cognitive Functioning in Normal Volunteers. Br J Clin Pharmacol 1981; 12: 819-24.
74. Mcelroy SL, Keck PE, Pope HG. Sodium valproate: its use in primary psychiatric disordeers. J Clin Psychopharmacol 1987; 7: 16-24.
75. Calabrese CS, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147: 431-34.
76. Pope HG, McElroy SL, Satlin TA et al. Head injury, bipolar disorder and response to valproate. Compr Psychiatry 1988; 29: 34-38.
77. Pies R, Adler DA, Ehrenberg BL. Sleep disorders and depression with atypical features: response to valproate. J Clin Psychopharmacol 1989; 9: 352-57.
78. Smith DB, Mattson RH, Cramer JA et al. Results of a Nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenythoin and primidone. Epilepsia 1987; 28: 50-58.
79. Meador KJ, Loring DW. Cognitive effects of antiepileptic drugs.En: Devinsky O, Theodore WH editores. Epilepsy and Behaviour. New York: Wiley-Liss 1991. p. 151-70.
80. Meador KJ, Loring DW, Allen ME et al. Comparative cognitive effects of carbamacepine and phenytoin in healthy aldults. Neurology 1991; 41: 1537-40.
81. Meador KJ, Loring DW, Abney OL et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993; 34: 153-57.
82. Meador KJ, Loring DW, Moore EE et al.. Comparative cognitive efffects of phenobarbital, phenytoin and valproate in healthy adults. Neurology 1995; 45: 1494-99.
83. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy lennox-gastaut syndrome. N Engl J Med 1993; 328: 29-33.
84. Dodson WE. Felbamate in the treatment of lennox-gastaut syndrome: results of a 12-month, open-label study following a randomized clinic trial. Epilepsia 1993; 34 Supp 7: 18-S24.
85. Dodrill CB, Willensky J, Ojemann LM. Neuropsychological mood and psychosocial effects of gabapentin [abstract]. Epilepsia 1992;. 3 (3): 117-18.
86. Arnett JL, Dodrill CB. Effects of gabapentin on cognitive functioning and mood [abstract]. Epilepsia 1995; 36(3): 32.
87. Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ. Behavioral side effects of gabapentin in children [abstract]. Epilepsia 1996; 37: 87-90.
88. Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition: a double-blind, dose-ranging, placebo-controlled study in refractory epilepsy [abstract.]. Journal of Neurlogy Neurosurgery and psychiatry 1997; 62: 372-76.
89. Smith D, Baker G, Davies G et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312-22.
90. Mervaala E, Koivisto K, Hänninen T et al. Electrophysiological and neuropsychological profiles of lamotrigine in young and age-associated memory impairment subjects [abstract]. Neurology 1995; 46 (4): 259.
91. Gillham RA, Blacklaw J, Mckee PJW et al. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1993; 53: 1271-75.
92. Grunawald RA, Thompson PJ, Corcoran R et al.. Effects of vigabatrin on partial seizures and cognitive function. J Neurol Neurosurg Psychiatry 1994; 57: 1057-63.
93. Kälviäinen R, Äikiä M, Saukkonen AM et al. Vigabatrin vs carbamazapine monotherapy in patients with newly diagnosed Epilepsy. Arch Neurol 1995; 52: 989-96.
94. Dodrill CB, Arnett JL, Sommerville KW et al.. Effects of differing dosages of vigabatrin on cognitive abilities and quality of life in epilepsy. Epilepsia 1995; 36: 164-73.
95. Provinciali L, Bartolini M, Mari F, Delpesce M. Influence of vigabatrin on cognitive performances and behavior in patients with drug-resistant epilepsy. Acta Neurologica Scandinvica 1996; 94: 12-18.
96. Monaco F. Cognitive effects of vigabatrin. Neurology 1996; 47(1):6-11.
97. Privitera M. Long-term cognitive effects of topiramate [abstract.]. Epilepsia 1995; 36 3: 152.
98. Burton LA, Harden C. Effect of topiramate on attention. Epilepsy Research 1997; 27: 29-32.
99. Bittermann HJ, Steinhoff BJ. Topiramate -an efficacious new antiepileptic drug- an open prospective study. Nervenartz 1997; 68: 86-38.
100. Sveinborjnsdottir S, Sander JWAS, Patsalos PN et al. Neuropsychological effects of tiagabine: a potential new antiepileptic drug. Seizure 1994; 3: 29-35.
101. Dodrill C, Arnett JL, Sommerville K, et al. Tiagabine [abstract]. Epilepsia 1995; 36 (3): 31.
102. Kälviäinen R, Äikiä M, Mervaala E et al.. Long-term cognitive effects of tiagabine [abstract]. Epilepsia 1995; 36 Supp 3: 149.
103. Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quallity of life of differing dosages of tiagabine in epiepsy. Neurology 1997; 48(4):1025-1031.